🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators analyze the clinical outcome of steroid withdrawal protoc...
Status
Unknown
Location
Ajou University Hospital
Start Date
2008-05
Trial ID
NCT01550445
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of haploident...
Status
Unknown
Location
First Affiliated Hospital of Guangxi Medical University
Start Date
2017-04-01
Trial ID
NCT03171831
Eligible patients will receive subcutaneous vaccinations of the hTERT/survi...
Status
Completed
Location
Abramson Cancer Center, University of Pennsylvania
Start Date
2012-06
Trial ID
NCT01660529
Treatments Being Tested
The primary aim of this study is to evaluate the safety and efficacy of EC-...
Status
Completed
Location
Multiple Locations
Start Date
2002-10
Trial ID
NCT00308425
Treatments Being Tested
This study is designed to determine the efficacy and safety of allogeneic b...
Status
Unknown
Location
The First Affiliated Hospital, Sun Yat-sen University
Start Date
2015-10
Trial ID
NCT02561767
This is a single-center, single-arm Phase Investigational Intervention Tria...
Status
Recruiting
Location
Shanghai Changzheng Hospital
Start Date
2021-09-14
Trial ID
NCT06196996
The purpose of this study is to compare the safety and efficacy of differen...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00113269
Treatments Being Tested
This study is a prospective, multicenter, open-label, phase II clinical tri...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-09-01
Trial ID
NCT07572669
The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Status
Terminated
Location
University of Alabama
Start Date
2011-09
Trial ID
NCT01436305
Treatments Being Tested
This is a Phase II/III, randomized, open-label, active-controlled, multicen...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00729768
Treatments Being Tested